175 related articles for article (PubMed ID: 36328858)
1. Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.
D'Addese L; Cantor RS; Koehl D; Reardon L; Ameduri R; Bock M; Morrison A; White S; Wisotzkey B; Kirklin JK; Godown J
J Heart Lung Transplant; 2023 Jan; 42(1):115-123. PubMed ID: 36328858
[TBL] [Abstract][Full Text] [Related]
2. Uncertain benefit of statins in pediatric heart transplant recipients: A PHTS analysis.
Townsend M; Khoury M; Koehl D; Kirklin JK; Cantor R; Beasley G; Chen CY; Boyle G; Parent JJ; Baez Hernandez N; Halnon N
J Heart Lung Transplant; 2024 May; 43(5):703-713. PubMed ID: 38065240
[TBL] [Abstract][Full Text] [Related]
3. Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation.
Bergmark BA; Zelniker TA; Kim M; Mehra MR; Stewart GC; Page DS; Woodcome EL; Givertz MM
Clin Transplant; 2021 Oct; 35(10):e14424. PubMed ID: 34254366
[TBL] [Abstract][Full Text] [Related]
4. Cardiac allograft vasculopathy in pediatric heart transplant recipients does early-onset portend a worse prognosis?
Khoury M; Conway J; Gossett JG; Edens E; Soto S; Cantor R; Koehl D; Barnes A; Exil V; Glass L; Kirklin JK; Zuckerman WA
J Heart Lung Transplant; 2022 May; 41(5):578-588. PubMed ID: 35172937
[TBL] [Abstract][Full Text] [Related]
5. Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathy.
Bjerre KP; Clemmensen TS; Berg K; Poulsen SH; Hvas AM; Grove EL; Løgstrup BB; Jakobsen L; Thim T; Kristensen SD; Eiskjær H
J Heart Lung Transplant; 2020 Apr; 39(4):371-378. PubMed ID: 32067865
[TBL] [Abstract][Full Text] [Related]
6. Early aspirin use and the development of cardiac allograft vasculopathy.
Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM
J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013
[TBL] [Abstract][Full Text] [Related]
7. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of third heart transplants in pediatric and young adult patients: analysis of the United Network for Organ Sharing database.
Friedland-Little JM; Gajarski RJ; Yu S; Donohue JE; Zamberlan MC; Schumacher KR
J Heart Lung Transplant; 2014 Sep; 33(9):917-23. PubMed ID: 24861821
[TBL] [Abstract][Full Text] [Related]
10. Obesity and dyslipidemia predict cardiac allograft vasculopathy and graft loss in children and adolescents post-heart transplant: A PHTS multi-institutional analysis.
Bogle C; Cantor R; Koehl D; Lochridge J; Kirklin JK; Barnes A; Wallis G; Amdani S; Ameduri R; Pahl E; Simpson KE; Blume ED
Pediatr Transplant; 2022 Aug; 26(5):e14244. PubMed ID: 35122464
[TBL] [Abstract][Full Text] [Related]
11. Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.
Asleh R; Briasoulis A; Smith B; Lopez C; Alnsasra H; Pereira NL; Edwards BS; Clavell AL; Stulak JM; Locker C; Kremers WK; Daly RC; Lerman A; Kushwaha SS
J Card Fail; 2021 May; 27(5):542-551. PubMed ID: 33962742
[TBL] [Abstract][Full Text] [Related]
12. Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.
Peled Y; Lavee J; Raichlin E; Katz M; Arad M; Kassif Y; Peled A; Asher E; Elian D; Har-Zahav Y; Shlomo N; Freimark D; Goldenberg I; Klempfner R
Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28990263
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection and allograft rejection among pediatric heart transplant recipients in the era of valganciclovir prophylaxis.
Das BB; Prusty BK; Niu J; Sue PK
Pediatr Transplant; 2020 Dec; 24(8):e13750. PubMed ID: 32573886
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents.
Greenway SC; Butts R; Naftel DC; Pruitt E; Kirklin JK; Larsen I; Urschel S; Knecht K; Law Y
J Heart Lung Transplant; 2016 Apr; 35(4):457-65. PubMed ID: 26746989
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
[TBL] [Abstract][Full Text] [Related]
16. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
[TBL] [Abstract][Full Text] [Related]
18. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
[TBL] [Abstract][Full Text] [Related]
19. Cardiac allograft vasculopathy and survival in pediatric heart transplant recipients transitioned to adult care.
Rodenas-Alesina E; Aleksova N; Stubbs M; Foroutan F; Kozuszko S; Posada JD; McDonald M; Moayedi Y; Ross H; Dipchand A
J Heart Lung Transplant; 2024 Feb; 43(2):229-237. PubMed ID: 37704160
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study.
Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E
J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
